Regulation 30 Update -Munjals And Burmans Modified Investment Proposal
This is in continuation to our letter Ref. No. FHL/SEC/STEX/RR/2018-19 dated April 23, 2018 whereby, it was informed that the Board of Directors of Fortis Healthcare Limited ('the Company') has received a letter, extending the validity period of Improved Offer till May 4, 2018, and all other terms and conditions of the Improved Offer remain unchanged, from Munjal's Office and Burman's Office with a proposal to invest in the Company....01-05-2018